|
| Exchange Received Time 05/11/2018 17:10:50 Exchange Disseminated Time 05/11/2018 17:10:56 Time Taken 00:00:06 | JAGSONPAL PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2018 ,inter alia, to consider and approve Sir,
Pursuant to Regulation 29 read with Regulation 47 of the SEBI Listing Obligation and Disclosure Requirements Regulation, 2015, we hereby give notice that the meeting of the Board of Directors of the Company is scheduled to be held on Wednesday, the 14/11/2018. inter-alia, to consider and approve the Un-audited Financial Results (Standalone) for the quarter ended 30th, September, 2018 and discuss other routine matters.
Further , it is Informed that as per Company's Code of Internal Procedures and Conduct for Regulating, Monitoring and Reporting by Insiders framed pursuant to the SEBI (Prohibition of Insider Trading) Regulations, 2015 the Trading window for dealing in the securities of the Company shall remain closed from, Monday, the 5th, November, 2018 to Friday, 16th, November, 2018. (both days inclusive).
This information is also be available on the Company's website at www.jagsonpal.com and on the website of BSE and NSE, where the Company's Equity Shares are listed
|
|
|